Age dependence of the risk of intussusception following [corrected] rhesus-human reassortant rotavirus tetravalent vaccine: is it beyond doubt?
The relation between the risk of intussusception and age at the time of receipt of the first dose of rhesus-human reassortant rotavirus tetravalent vaccine (RRV-TV) has been studied extensively on the basis of Centers for Disease Control and Prevention (CDC) matched case-control study data, using various statistical methods, including conditional logistic regression and quadratic smoothing splines. However, different conclusions have been reported in published analyses regarding the dependence of the risk of intussusception on age at first dose. The authors reanalyzed the CDC matched case-control data set using unrestricted and restricted quadratic smoothing spline methods for various exposure windows (i.e., intervals postvaccination). These analyses indicated that the use of different models may lead to different conclusions. The restricted quadratic smoothing spline with appropriately chosen knot locations showed a statistically significant increased risk of intussusception associated with RRV-TV for the exposure window 3-14 days after the first dose at an age as young as 49 days, the youngest age in the data set at which vaccine was administered; this implies an increased risk of intussusception associated with RRV-TV at all ages studied.
Chen
Jie
J
Department of Global Surveillance and Pharmacoepidemiology, Abbott Laboratories, Abbott Park, Illinois, USA.
Heyse
Joseph F
JF
Heaton
Penny
P
Kuter
Barbara J
BJ
D000367:Age Factors; D016022:Case-Control Studies; D015331:Cohort Studies; D004334:Drug Administration Schedule; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007443:Intussusception / Q000453:epidemiology*; D016015:Logistic Models; D016017:Odds Ratio; D012307:Risk Factors; D022243:Rotavirus Vaccines / Q000008:administration & dosage*; D014481:United States / Q000453:epidemiology
D022243:Rotavirus Vaccines; C052014:rhesus rotavirus vaccine